S&P 500 Industrials Sector SEC Filings — February 01, 2026

02-02-2026

Fifth Third Bancorp filed an 8-K on 2026-02-02 reporting completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), material modifications to rights of security holders (Item 3.03), departure of directors/officers, election of directors, appointment of officers, and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative financial metrics, deal values, parties involved, synergies, or impacts were disclosed, resulting in no identifiable positive or negative performance indicators.

02-02-2026

Huntington Bancshares Inc. filed an 8-K on 2026-02-02 disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing also reports material modifications to rights of security holders (Item 3.03), departures or elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03), alongside other events (Item 8.01) and financial statements/exhibits (Item 9.01). No specific transaction details, parties, financial metrics, or performance comparisons are disclosed.

• ·Filing Accession Number: 0001140361-26-003083
• ·File size: 318 KB
• ·No quantitative metrics, deal size, parties beyond filer, or performance data disclosed

02-02-2026

Lottery.com Inc. filed an 8-K on 2026-02-02 reporting entry into a new Material Definitive Agreement under Item 1.01 and termination of a prior Material Definitive Agreement under Item 1.02. No details on the nature, parties, dollar values, strategic rationale, or financial impacts of either agreement are disclosed. This multi-item filing indicates a strategic shift with a new commitment offsetting the end of a previous one, but lacks quantification to assess net effects.

02-02-2026

Global Net Lease, Inc. filed an 8-K on February 02, 2026 (AccNo: 0001104659-26-008874, Size: 381 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of potentially material information via Reg FD and attached exhibits. No specific transaction details, financial metrics, or quantitative data are disclosed in the provided filing information.

02-02-2026

PotlatchDeltic Corp filed an 8-K on 2026-02-02 announcing the completion of an acquisition or disposition of assets under Item 2.01, notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01, material modifications to rights of security holders under Item 3.03, changes in control of the registrant under Item 5.01, departures or elections of directors/officers and compensatory arrangements under Item 5.02, and amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03. Item 9.01 includes financial statements and exhibits. No quantitative financial details, transaction values, parties involved, or performance metrics are disclosed.

02-02-2026

IDEXX Laboratories Inc filed an 8-K on February 2, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative metrics, guidance, or other quantitative details are available.

02-02-2026

Venture Global, Inc. filed a Form 8-K on 2026-02-02 under Item 1.01 disclosing entry into a material definitive agreement. No specific details on the agreement's parties, transaction value, financial terms, strategic rationale, or impacts were provided. This mandatory disclosure signals a potentially significant event, but lacks quantitative data for impact assessment.

02-02-2026

TTM Technologies Inc filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation, reasons, or timing are provided in the available information. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

02-02-2026

Eton Pharmaceuticals, Inc. filed a Form 8-K on February 2, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed in the provided filing summary. This is a multi-item informational filing with no quantified metrics, impacts, or directional biases reported.

02-02-2026

Stoneridge Inc. filed an 8-K on February 02, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. The filing also covers Item 5.02 changes in directors or certain officers, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No quantitative metrics, deal values, parties involved, or financial terms are disclosed.

02-02-2026

Skyline Bankshares, Inc. filed a Form 8-K on 2026-02-02 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific quantitative financial metrics, revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other numerical data were explicitly stated in the provided filing information. This appears to be a standard voluntary earnings-related disclosure.

02-02-2026

Quantum Corp /DE/ filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with additional Other Events under Item 8.01 and exhibits under Item 9.01. No specific details such as the key position affected, names of individuals, appointment or resignation status, reasons for the change, or any quantitative data are disclosed in the provided filing summary. No positive or negative metrics, financial impacts, or performance comparisons are mentioned.

02-02-2026

Sierra Bancorp filed an 8-K on 2026-02-02 under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, or other quantitative financial details are provided in the filing summary. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

02-02-2026

Devon Energy Corp filed a multi-item 8-K on February 2, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01, departure/election/appointment of directors/officers and compensatory arrangements under Item 5.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No quantitative details, transaction values, personnel names, financial impacts, or performance metrics (positive, negative, or flat) are provided in the filing summary. This requires review of exhibits for full context.

02-02-2026

Carter Bankshares, Inc. filed a Form 8-K on February 02, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. All impacts, changes, and scheduled events are NOT_DISCLOSED.

02-02-2026

Claros Mortgage Trust, Inc. filed a multi-item Form 8-K on February 2, 2026, reporting entry into a material definitive agreement (Item 1.01) alongside termination of another material definitive agreement (Item 1.02). The filing also discloses creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No quantitative details, dollar values, or specific impacts were disclosed.

02-02-2026

Newbridge Acquisition Ltd filed an 8-K on 2026-02-02 disclosing entry into a Material Definitive Agreement under Item 1.01, likely related to a merger or acquisition, along with unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws and/or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No quantitative metrics, deal terms, parties beyond the filer, valuations, synergies, or performance comparisons (positive, negative, or flat) are disclosed. Critical details such as target company, deal structure, consideration, and timeline remain NOT_DISCLOSED.

02-02-2026

Northfield Bancorp, Inc. filed a Form 8-K on 2026-02-02 disclosing entry into a material definitive agreement under Item 1.01, departure/election/appointment of directors/officers and compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. No specific details on the agreement, personnel changes, financial impacts, transaction values, or quantitative metrics are provided in the filing summary. This is a multi-item informational filing with no disclosed positive or negative financial metrics.

02-02-2026

NIQ Global Intelligence plc filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, departure or appointment of directors or certain officers including compensatory arrangements under Item 5.02, and financial statements and exhibits under Item 9.01. No specific details on officer positions, reasons for change, financial metrics, or performance comparisons are disclosed. No quantitative data or directional impacts are provided.

02-02-2026

Plumas Bancorp filed a Form 8-K on February 02, 2026 (AccNo: 0001437749-26-002609, Size: 182 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed in the filing summary. This multi-item filing appears informational with no quantified positive or negative metrics provided.

02-02-2026

Barnwell Industries Inc filed a Form 8-K on 2026-02-02 reporting under Item 1.01 entry into a material definitive agreement, under Item 3.03 material modifications to rights of security holders, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details provided on the agreement, modifications, events, transaction values, financial impacts, or quantitative metrics. No positive or negative performance metrics are disclosed.

02-02-2026

F&M BANK CORP filed an 8-K on February 2, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

02-02-2026

Advanced Drainage Systems, Inc. filed an 8-K on 2026-02-02 disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific transaction details, parties, values, or financial metrics were disclosed in the provided filing summary.

02-02-2026

Flutter Entertainment plc filed a Form 8-K on 2026-02-02 under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits, with Accession Number 0001193125-26-033050 and file size 137 KB. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the filing summary. This is a voluntary informational disclosure without apparent positive or negative performance indicators.

02-02-2026

CAPITAL CITY BANK GROUP INC filed an 8-K on February 02, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary disclosure of material non-public information with attached exhibits, but specific details of the disclosure, financial metrics, transactions, or events are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or directional impacts are provided in the filing summary.

02-02-2026

International Bancshares Corp filed a Form 8-K on February 02, 2026 (AccNo: 0001104659-26-009083, Size: 195 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, transactions, or directional impacts are mentioned.

02-02-2026

HERITAGE FINANCIAL CORP /WA/ filed an 8-K on 2026-02-02 under Item 2.01 announcing the completion of an acquisition or disposition of assets. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No quantitative deal terms, parties involved, strategic rationale, or financial metrics are disclosed.

02-02-2026

OptimumBank Holdings, Inc. filed a Form 8-K on 2026-02-02 reporting results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

02-02-2026

PROVECTUS BIOPHARMACEUTICALS, INC. filed a Form 8-K on 2026-02-02 disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, accompanied by Item 9.01 Financial Statements and Exhibits. No specific details on the nature, effective date, or impact of the amendments or changes are provided. No quantitative financial metrics, positive or negative changes, or other performance data are mentioned.

02-02-2026

Regen BioPharma Inc filed an 8-K on February 2, 2026, specifically under Item 3.02 disclosing unregistered sales of equity securities. No quantitative details such as transaction value, share count, proceeds, or buyer information are disclosed. This is a single-item mandatory filing with no additional positive or negative metrics provided.

02-02-2026

Capitol Federal Financial, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individual involved, nature of change (appointment or resignation), reasons, or timing are provided. No quantitative data, financial metrics, or further governance implications are mentioned.

02-02-2026

Hormel Foods Corp /DE/ filed an 8-K on February 2, 2026, disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), submission of matters to a vote of security holders under Item 5.07, and financial statements and exhibits under Item 9.01. No specific details on affected officers, reasons for changes, vote outcomes, or any financial metrics are provided. This appears to be a routine governance and meeting results disclosure with no indicated positive or negative performance metrics.

02-02-2026

Shore Bancshares Inc filed an 8-K on February 02, 2026 under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, or other quantitative details are disclosed in the filing summary provided. No positive or negative performance indicators are mentioned.

02-02-2026

MIRA PHARMACEUTICALS, INC. filed a Form 8-K on February 02, 2026, under Item 8.01 Other Events. No specific details of the event, financial metrics, quantitative data, or period-over-period comparisons are disclosed in the provided filing information. This is a single-item voluntary disclosure with no mentioned positive or negative impacts.

02-02-2026

Peoples Bancorp Inc filed an 8-K on 2026-02-02 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary filing to disclose material non-public information in compliance with Regulation FD and attach relevant exhibits. No financial metrics, transactions, or other quantitative details are explicitly stated in the filing summary provided.

02-02-2026

GENELUX Corp filed an 8-K on February 02, 2026 (AccNo: 0001493152-26-004755, size: 40 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material nonpublic information pursuant to Regulation FD with attached exhibits, but no specific transaction details, financial metrics, or events are stated in the provided summary. No quantitative data, period-over-period comparisons, or directional metrics (positive, negative, or flat) are mentioned.

02-02-2026

FEDERAL AGRICULTURAL MORTGAGE CORP filed an 8-K on February 02, 2026, reporting amendments to its Articles of Incorporation or Bylaws or a change in fiscal year under Item 5.03, with financial statements and exhibits provided under Item 9.01. No specific details on the nature or impact of the amendments, quantitative metrics, transaction values, or financial implications are disclosed in the filing summary. This appears to be an informational governance update with no directional financial data provided.

02-02-2026

FIRST FINANCIAL BANCORP /OH/ filed an 8-K on 2026-02-02 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with a filing size of 9 MB. No specific financial metrics, transactions, positive or negative changes, or operational details are disclosed in the provided filing summary. This appears to be a voluntary disclosure to comply with Regulation FD, potentially including attached exhibits such as presentations.

• ·AccNo: 0000708955-26-000011
• ·Filing size: 9 MB
• ·Event Type: General Filing
• ·Multi-item 8-K: Items 7.01 and 9.01

02-02-2026

Bally's Corp filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any named executives are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.

02-02-2026

S&T Bancorp Inc filed an 8-K on February 2, 2026, reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, or period-over-period comparisons are disclosed in the provided filing information.

02-02-2026

Quaint Oak Bancorp, Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0000927089-26-000017), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing for financial results announcement. No specific revenue, earnings, balance sheet changes, guidance, or quantitative metrics are detailed in the provided filing information.

02-02-2026

Third Coast Bancshares, Inc. filed an 8-K on February 2, 2026, disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing also reports departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, along with Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No quantitative metrics, transaction details, or performance comparisons are explicitly stated.

02-02-2026

Bark, Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0001628280-26-004626), disclosing an unspecified event under Item 8.01 (Other Events). No financial metrics, transaction details, quantitative data, positive or negative changes, or operational impacts were mentioned. Sector information was not specified.

02-02-2026

Prosperity Bancshares Inc filed an 8-K on February 2, 2026, reporting under Item 8.01 Other Events, which covers material events not specified in other items, and Item 9.01 Financial Statements and Exhibits, indicating attached documents such as press releases or agreements. No specific details on the nature of the event, transaction values, financial metrics, or impacts are disclosed in the provided filing information. This is an informational filing with no quantitative data or directional implications available.

02-02-2026

APARTMENT INVESTMENT & MANAGEMENT CO filed a Form 8-K on February 02, 2026, disclosing an unspecified Other Event under Item 8.01. No quantitative data, financial impacts, transaction details, or other metrics are mentioned in the filing information provided. This is a voluntary single-item disclosure with no further specifics on the event.

02-02-2026

Avidia Bancorp, Inc. filed an 8-K on February 2, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

02-02-2026

Farmers & Merchants Bancorp filed a Form 8-K on February 2, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely providing material non-public information previously disclosed selectively, with supporting exhibits attached. No specific financial metrics, transactions, or performance details are disclosed in the filing summary.

02-02-2026

Lexicon Pharmaceuticals, Inc. filed a Form 8-K on February 2, 2026, reporting multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction values, financial metrics, share counts, or directional impacts were disclosed. The filing appears informational without quantified positive or negative metrics.

02-02-2026

NRX Pharmaceuticals, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, or any quantitative metrics are provided. No positive or negative performance metrics are mentioned.

02-02-2026

SunPower Inc. filed an 8-K on 2026-02-02 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also reports unregistered sales of equity securities (Item 3.02) and attaches financial statements and exhibits (Item 9.01). No specific transaction details, parties, values, or metrics are disclosed.

02-02-2026

ImmuCell Corp filed an 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific transaction details, personnel names, financial impacts, dollar values, or quantitative metrics are disclosed.

02-02-2026

DALRADA FINANCIAL CORP filed an 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, terms, financial impacts, or quantitative metrics are disclosed in the provided filing summary.

02-02-2026

Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or financial metrics are disclosed.